Rchr
J-GLOBAL ID:201301012295496273   Update date: Dec. 19, 2022

Nomura Wataru

ノムラ ワタル | Nomura Wataru
Affiliation and department:
Job title: Professor
Homepage URL  (2): https://www.hiroshima-u.ac.jp/pharm/research/lab/Genome_and_Biomolecular_Engineering_for_Drug_Discoveryhttps://www.hiroshima-u.ac.jp/en/pharm/research/lab/Genome_and_Biomolecular_Engineering_for_Drug_Discovery
Research field  (4): Pharmaceuticals - health and biochemistry ,  Chemical biology ,  Biochemistry ,  Molecular biochemistry
Research keywords  (18): ウイルス ,  がん ,  エイズ ,  合成生物 ,  ゲノム ,  遺伝子 ,  DNA組換え ,  ヌクレアーゼ ,  亜鉛 ,  メチル化 ,  DNA ,  生物化学 ,  分子生物 ,  ケミカルバイオロジー ,  バイオ ,  創薬 ,  ペプチド ,  タンパク質
Research theme for competitive and other funds  (13):
  • 2016 - 2018 ゲノム編集技術によるタグ導入を利用した新生タンパク質初期動態観察法の構築
  • 2016 - 2017 タンパク質新生の超解像・迅速追跡を志向した高輝度タグ-プローブシステムの構築
  • 2015 - 2017 ペプチドミメティックを活用した中分子型創薬リードの創製
  • 2014 - 2015 哺乳類細胞での合成生物学を志向した次々世代型ジェネティックエンジニアリング技術
  • 2013 - 2015 DNA結合ドメインの特長を生かしたDNA修飾酵素の開発とゲノム編集への応用
Show all
Papers (163):
MISC (9):
Books (18):
  • 人工酵素によるゲノム編集工学とその応用、可能性. 薬学雑誌(日本薬学会 東京)
    2015
  • Development of Dimeric Peptide Derivatives Based on gp41 Fragments as HIV-1 Fusion Inhibitors. in "Peptide Science 2014," ed. by Akira Otaka, The Japanese Peptide Society, Osaka
    2015
  • Development of 8-Azacoumarin-4-ylmethyl-type Photolabile Protecting Groups Based on Amide-Alkene Isosterism. in "Peptide Science 2014," ed. by Akira Otaka, The Japanese Peptide Society, Osaka
    2015
  • Design and Synthesis of Trivalent CXCR4 Ligands Utilizing Polyproline Linkers. in "Peptide Science 2014," ed. by Akira Otaka, The Japanese Peptide Society, Osaka
    2015
  • Synthesis and Evaluation of CXCR4-derived Peptides Targeting the Development of AIDS Vaccines. Proceedings of the 5th International Peptide Symposium in conjunction with the 47th Japanese Peptide Symposium, 103, 2011.
    Nobutaka Fujii and Yoshiaki Kiso (Eds.), The Japanese Peptide Society, Kyoto, Japan 2011
more...
Lectures and oral presentations  (274):
  • 迅速型発蛍光イメージングによる新生タンパク質の動態解析
    (第50回若手ペプチド夏の勉強会 2018)
  • Development of HIV-1 fusion inhibitors based on the C34 dimers derived from gp41
    (The 13th Annual Meeting of Japanese Society for Chemical Biology 2018)
  • Development of NanoBRET assay system in living cells to search potent CXCR4 ligands
    (日本ケミカルバイオロジー学会第13回年会 2018)
  • Peptide-based fluorescent imaging tools for observation of target protein dynamics
    (138th Annual Meeting of the Pharmaceutical Society of Japan 2018)
  • HIV外被タンパク質gp41由来断片ペプチドC34を基にした二価型膜融合阻害剤の創製
    (日本薬学会第138年会 2018)
more...
Education (2):
  • - 2005 Kyoto University Graduate School, Division of Pharmaceutical Sciences
  • - 2000 Kyoto University Faculty of Pharmaceutical Science
Professional career (1):
  • Ph.D. (Kyoto University)
Work history (11):
  • 2015/04/01 - 現在 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Life Science and Technology Life Science and Technology Medicinal Chemistry Associate Professor
  • 2015/04/01 - 現在 Tokyo Medical and Dental University Institute of Biomaterials and Bioengineering Biomolecular Chemistry Medicinal Chemistry Associate Professor
  • 2013/04/01 - 2015/03/31 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Life Science and Technology Life Science and Technology Molecular Biomedicine Associate Professor
  • 2012/01/01 - 2013/03/31 Tokyo Medical and Dental University Institute of Biomaterials and Bioengineering Biomolecular Chemistry Medicinal Chemistry Junior Associate Professor
  • 2007/08/01 - 2011/12/31 Tokyo Medical and Dental University Institute of Biomaterials and Bioengineering Biomolecular Chemistry Medicinal Chemistry Assistant Professor
Show all
Awards (4):
  • 2016/09 - 日本薬学会関東支部奨励賞(野村渉)
  • 2013/11 - 日本ペプチド学会 日本ペプチド学会奨励賞
  • 2010 - 薬学会ハイライト. 日本薬学会第130年会
  • 2009 - 第3回日本エピジェネティクス研究会年会長賞
Association Membership(s) (3):
American Chemical Socisty ,  日本分子生物学会 ,  日本生化学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page